DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
173 hedge funds and large institutions have $1.25B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
44% less capital invested
Capital invested by funds: $2.22B → $1.25B (-$973M)
50% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 56
Holders
173
Holding in Top 10
5
Calls
$15.1M
Puts
$4.49M
Top Buyers
| 1 | +$26.1M | |
| 2 | +$26.1M | |
| 3 | +$25.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$16.1M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$15.7M |
Top Sellers
| 1 | -$58.2M | |
| 2 | -$55.8M | |
| 3 | -$29.9M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$18.5M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$16.9M |